Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

53.74
Delayed Data
As of Jan 13
 +0.35 / +0.66%
Today’s Change
38.26
Today|||52-Week Range
54.72
+0.39%
Year-to-Date
ZTS Regular Dividend: ZTS will begin trading ex-dividend on 01/18/17 with a $0.105 dividend payable to shareholders of record as of 01/20/17.

Today’s Trading

Previous close53.39
Today’s open53.55
Day’s range53.35 - 53.88
Volume2,458,676
Average volume (3 months)3,404,141
Market cap$26.5B
Dividend yield0.78%
Data as of 01/13/2017

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+9.73%
Earnings growth (next 5 years)+14.17%
Revenue growth (last year)-0.42%
P/E ratio38.7
Price/Sales5.05
Price/Book25.03

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-0.06-0.13%
ALXNAlexion Pharmaceutic...-0.42-0.31%
INCYIncyte Corp+0.20+0.17%
VRTXVertex Pharmaceutica...+0.78+0.95%
Data as of 4:00pm ET, 01/13/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.46
Annual revenue (last year)$4.8B
Annual profit (last year)$339.0M
Net profit margin7.11%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
Florham Park, New Jersey

Forecasts


Search for Jobs